Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer
Clinical trial NCT05377788 · UNKNOWN
Trial details
- NCT number
- NCT05377788
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-31
- Primary completion
- 2024-06-30
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.